Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 263

Similar articles for PubMed (Select 15813744)

1.

Regulation of azole drug susceptibility by Candida albicans protein kinase CK2.

Bruno VM, Mitchell AP.

Mol Microbiol. 2005 Apr;56(2):559-73.

PMID:
15813744
2.

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.

Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86.

4.

RTA2, a novel gene involved in azole resistance in Candida albicans.

Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.

Biochem Biophys Res Commun. 2008 Sep 5;373(4):631-6. doi: 10.1016/j.bbrc.2008.06.093. Epub 2008 Jul 2.

PMID:
18601908
6.

Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.

Coste AT, Ramsdale M, Ischer F, Sanglard D.

Microbiology. 2008 May;154(Pt 5):1491-501. doi: 10.1099/mic.0.2007/016063-0.

7.

Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.

Holmes AR, Tsao S, Ong SW, Lamping E, Niimi K, Monk BC, Niimi M, Kaneko A, Holland BR, Schmid J, Cannon RD.

Mol Microbiol. 2006 Oct;62(1):170-86. Epub 2006 Aug 30.

PMID:
16942600
8.

Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.

Shen H, An MM, Wang de J, Xu Z, Zhang JD, Gao PH, Cao YY, Cao YB, Jiang YY.

Biol Pharm Bull. 2007 Jan;30(1):68-73.

9.

Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.

Maebashi K, Niimi M, Kudoh M, Fischer FJ, Makimura K, Niimi K, Piper RJ, Uchida K, Arisawa M, Cannon RD, Yamaguchi H.

J Antimicrob Chemother. 2001 May;47(5):527-36.

10.

Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.

Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.

FEMS Yeast Res. 2009 Jun;9(4):618-25. doi: 10.1111/j.1567-1364.2009.00504.x. Epub 2009 Mar 30.

11.

Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.

Maesaki S, Marichal P, Hossain MA, Sanglard D, Vanden Bossche H, Kohno S.

J Antimicrob Chemother. 1998 Dec;42(6):747-53.

12.

Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.

Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD.

Mol Microbiol. 2006 Aug;61(3):704-22. Epub 2006 Jun 27.

PMID:
16803598
13.

ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.

Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD.

Antimicrob Agents Chemother. 2008 Nov;52(11):3851-62. doi: 10.1128/AAC.00463-08. Epub 2008 Aug 18.

14.

New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.

Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.

J Med Vet Mycol. 1997 Mar-Apr;35(2):133-7.

PMID:
9147273
15.

Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.

Tsao S, Rahkhoodaee F, Raymond M.

Antimicrob Agents Chemother. 2009 Apr;53(4):1344-52. doi: 10.1128/AAC.00926-08. Epub 2009 Feb 17.

16.

CRZ1, a target of the calcineurin pathway in Candida albicans.

Karababa M, Valentino E, Pardini G, Coste AT, Bille J, Sanglard D.

Mol Microbiol. 2006 Mar;59(5):1429-51.

PMID:
16468987
17.

The genetic basis of fluconazole resistance development in Candida albicans.

Morschhäuser J.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):240-8. Review.

PMID:
12084466
18.
19.

Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.

Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD.

J Antimicrob Chemother. 2004 Dec;54(6):999-1006. Epub 2004 Oct 14.

20.

A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains.

Kusch H, Biswas K, Schwanfelder S, Engelmann S, Rogers PD, Hecker M, Morschhäuser J.

Mol Genet Genomics. 2004 Jun;271(5):554-65. Epub 2004 Apr 28.

PMID:
15114480
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk